Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

COVID-19 antibodies advance and get US funding

9 October 2020 21:30 BST COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442rapidly advances into Phase III clinical trials Two trials of AZD7442 will enrol over 6,000 adults for the prevention of COVID-19 withadditional trials enrolling ~4,000 adults for the treatment of SARS-CoV-2 infections US Government to invest ~$486m for development and supply of up to 100,000 doses and can acquire another one million doses AstraZeneca's long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in

English version of PR published 20201012 at 07.33AM     SynAct Pharma completes part 1 of clinical phase II study with AP1189 in Rheumatoid Arthritis

SynAct Pharma AB ("SynAct") today announced that dosing of the leading candidate drug AP1189 was successfully completed in the second cohort (100 mg dose level) in part 1 of the company’s Phase IIa study in patients with Rheumatoid Arthritis (RA) with high disease activity.A data review on blinded non-validated data from 15 patients in the cohort of 100 mg dosing suggests that the compound is safe and well tolerated and shows that two thirds of the patients (10/15 patients) had a reduction in disease activity from severe to moderate or low disease activity during the 4 weeks treatment

SimCorp EMEA Signs non-binding Term Sheet with State Street Bank International GmbH

Company Announcement no. 38/2020 SimCorp EMEA and its current client State Street Bank International GmbH have today signed a non-binding Term Sheet setting out the main terms for entering into a strategic business partnership between the parties. The intention being to form a business partnership to provide a premier, fully integrated, front-to-back investment outsourcing solution for insurance firms in Europe, Middle East and Africa (EMEA). If and when the Term Sheet translates into a final strategic agreement, such agreement will become a "large contract" and SimCorp will disclose

Tokmanni’s financial information and Annual General Meeting in 2021

Tokmanni Group Corporation     Stock exchange release     12 October 2020 at 8:30 a.m.Tokmanni Group Corporation will publish its Financial Statement Release, Half Year Financial Report and two Business Reviews during 2021 as follows: 12 February 2021: Financial Statements Review for 202029 April 2021: Business Review for January-March 202129 July 2021: Half Year Financial Review for January-June 202129 October 2021: Business Review for January-September 2021 The 2020 Report by the Board of Directors and Financial Statements will be published during week 8. Tokmanni's Annual

Nomination Committee appointed for the Annual General Meeting 2021

The Nomination Committee ahead of the 2021 consists of: · Erik Malmberg, Actor SCA, Chair of the Nomination Committee · Carl Gustafsson, Didner & Gerge Fonder AB · Suzanne Sandler, Handelsbanken Fonder AB · Lena Hofsberger, Chair of Ambea AB (publ). Shareholders who wish to submit proposals to the Nomination Committee can do so on the following e-mail address: valberedning@ambea.se or to below address: Ambea ABValberedningenc/o Jacob Persson Box 1565SE-171 29 Solna, Sweden The Nomination Committee’s proposals shall be presented in the convening notice made

Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors

Oslo, 12 October 2020: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announce that the European Patent Office has granted European Patent no 3293201. The patent covers the use of ONCOS-102 in combination with checkpoint inhibitors.Torbjørn Furuseth, Chief Financial Officer of Targovax, said: "We are delighted that this European patent has been granted, further strengthening Targovax's intellectual property portfolio covering the very important combination of ONCOS-102

Leading Scandinavian accounting firm with strategic partnership with 24SevenOffice

ECIT AS, which is one of the largest accounting firms in Scandinavia with 1,400 employees and close to 1,6 billion SEK in revenue, establishes a strategic business unit specialized on 24SevenOffice technology including AI accounting, and best practice. ECIT will through that business unit acquire new accounting firms mainly in Norway and Sweden where all portfolio companies will use the 24SevenOffice accounting/ERP system.ECIT has made a strategic choice to only focus on the AI (Artificial Intelligence) powered 24SevenOffice accounting/ERP system in all the acquired accounting firms. ECIT

First day of trading in warrants of series TO1 and TO2 has been set for October 14, 2020

As previously announced, Cereno Scientific AB (”Cereno” or the ”Company”) has carried out a directed issue of shares and warrants of series TO1 and TO2 with issue funds of approximately SEK 60 million (the “Directed Issue”). In addition to the Directed Issue, the Company has simultaneously issued warrants of series TO1 and TO2 granted to (i) the Companys’s existing shareholders as compensation for the dilution caused by the Directed Issue and to (ii) Formue Nord Fokus A/S in its capacity as lender. The Company hereby announces that the first day for trading for the warrants of series TO1 and

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.10.2020

United Bankers Corporation NOTIFICATION 09.10.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.10.2020 Date 09.10.2020Exchange transaction BuyShare class UNIAVAmount 485Average price/share 9.0000 EURHighest price/share 9.0000 EURLowest price/share 9.0000 EURTotal price 4,365.00 EUR The shares held by United Bankers Corporation on 09.10.2020: UNIAV 20,802   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Aspire Global has Finalized the Acquisition of the Leading B2B Sportsbook Provider BtoBet

Aspire Global  has finalized the acquisition of 100% of the shares of BtoBet Ltd, a leading B2B sportsbook and technology provider. The acquisition of BtoBet, together with the acquisition last year of the leading aggregator and games studio Pariplay, has positioned Aspire Global among the world’s leading iGaming suppliers.The acquisition of BtoBet was announced on 17 September 2020 and following approval by North Macedonian authorities the transaction has been closed according to the initial conditions. BtoBet is consolidated as of 1 October 2020 by Aspire Global.

Extraordinary General Meeting of Sivers IMA has decided that the company's new name shall be Sivers Semiconductors

KISTA, Sweden, October 9[th], 2020 - Sivers IMA Holding AB (Nasdaq First North Growth Market: SIVE) publishes the statement from the Extraordinary General Meeting held today at the company's office in Kista.At the Extraordinary General Meeting, it was unanimously decided to change the company name of Sivers IMA to Sivers Semiconductors AB. Further, the Board can inform that Sivers IMA AB will be renamed Sivers Wireless AB and that Compound Semiconductor Technologies Global Ltd. will be renamed Sivers Photonics Ltd. For more information please contact:  Anders Storm, CEOTel: +46

SSM summons to a meeting with bondholders through a procedure in writing

At the request of SSM Holding AB (“SSM”), the agent has today summoned a meeting with the company’s bondholders by way of a procedure in writing to resolve on amending the terms and conditions of SSM’s outstanding bonds. The purpose of the amendment is to enable SSM to list the bonds with Nasdaq First North.At the request of SSM, the agent has today summoned a meeting with the company’s bondholders (the “Holders”) through a procedure in writing (the “Written Procedure”) to resolve on amending the terms and conditions of SSM’s outstanding bonds of a maximum of MSEK 700.0 (of which MSEK 300.0

#20-363 Changes to certain instruments on NGM

As from October 12, 2020, certain instruments are subject to changes.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-362 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-361 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Flagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets Act

Basware Corporation, stock exchange release, October 9, 2020 at 5.35 pm EESTBasware Corporation has received on October 9, 2020 the following notification pursuant to Chapter 9, Section 5 of the Finnish Securities Market Act from Briarwood Chase Management LLC according to which their total holding of financial instruments has increased above five (5) percent and total holding of both shares and financial instruments has increased above ten (10) percent of the total number of shares and votes in Basware Corporation on October 8, 2020. Basware Corporation has one series of shares in which

Flagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets Act

Basware Corporation, stock exchange release, October 9, 2020 at 5.30 pm EESTBasware Corporation has received on October 9, 2020 the following notification pursuant to Chapter 9, Section 5 of the Finnish Securities Market Act from Bregal Milestone General Partner Jersey Limited according to which Bregal Milestone L.P.’s total holding of financial instruments has decreased to zero (0) percent of the total number of shares and votes in Basware Corporation on October 8, 2020. Basware Corporation has one series of shares in which each share carries one vote. The total number of shares and

Pricer’s Net Sales and Operating Result in Third Quarter of 2020 are expected to exceed market expectations

Pricer AB improves net sales and operating profit in the third quarter of 2020 and are expected to exceed market expectations.Pricer, supplier of systems and solutions for in-store digitalization, has had a record high delivery activity during the third quarter. Net sales in the third quarter of 2020 are estimated to amount to approximately SEK 565 million, which corresponds to a growth of 143% compared with the third quarter of 2019. The operating profit for the third quarter of 2020, which has not yet been finally determined, is estimated to amount to approximately SEK 75 million

Indiana Marks One Year Anniversary With 22.3 Percent Growth in September Handle

Iselin, New Jersey - World Sports Network on the one year anniversary of legal sports betting in Indiana the September sports betting handle has an increase of 22.3% from last month , a 489.0% increase from this time last year when sports betting was legalized in the state. "Bettor confidence in regards to how much and how often they feel safe to wager their money is a clear temperature test for the economy as a whole as it singles out consumer financial confidence in a way that only the stock market has previously

Mandatory notification of trade

David B. Cook, Chief Executive Officer of Norwegian Energy Company ASA ("Noreco" or "the Company"), has on 9 October 2020 purchased 1,700 shares in Noreco at a price of NOK 139.451 per share. David B. Cook owns 5,200 shares in Noreco after the transaction and has the right to acquire or subscribe up to 300,000 additional shares in the Company, in aggregate 305,200 shares. This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.  ***

Benoit Hanssen is Joining CellRebel as a New Board Member

Benoit Hanssen is joining the CellRebel board, effective from October 8[th] 2020. Benoit is of Dutch nationality and currently works as Chief Technology Officer at Wind Tre SpA. He is based in Milan. Benoit has more than 20 years of experience in the telecom industry and previously had roles as CTO of Vodafone Australia and Hutchison Indonesia. He also worked at Ericsson for more than 10 years, including as head of Ericsson's global managed services operations. Benoit holds an MSc in Electrical Engineering from Eindhoven University of Technology and an MBA from Webster University

Zwipe AS - Registration of share capital increase

OSLO, NORWAY – 09 October 2020- The share capital increase pertaining to the 333,333 new shares in the Private Placement allocated to the chair of the board of directors, Jörgen Lantto, as resolved by the board of directors of Zwipe AS on 7 September 2020 and approved by the extraordinary general meeting on 29 September 2020, has today been registered in the Norwegian Register of Business Enterprises. The new share capital is NOK 3,190,657.60, and the new number of shares and votes is 31,906,576. ### About Zwipe Zwipe is pioneering the next generation contactless payments

Calmark receives order from Triolab Finland - clarification

Clarification: Calmark Sweden AB's press release from today at 14:00 regarding order from Triolab Finland is of strategic importance as it shows that Calmark's distributor has now started demonstrations and active sales work. The economic value of the order is of minor importance.This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 9 October 2020, 15:30 CEST.  Every care has been taken in the translation of this

Scandion Oncology announces that the warrant exercise is registered at the Danish Companies Registration Office

Scandion Oncology A/S ("Scandion Oncology") today, October 9, 2020, announce that the share capital increase from the warrant exercise with the subscription period that ended last week has been registered at the Danish Companies Registration Office.A total of 2,371,455 new shares have been registered at Erhvervsstyrelsen, which means that the total number of shares in Scandion Oncology now amount to 21,423,696. The share capital amounts to DKK 1,574,641.65. Conversion of interim shares to shares is expected to take place on October 16, 2020. Different banks may take a different amount of

There are no items matching the current filter
There are no more items matching the current filter
Back to top